Articles published by LEO Pharma
Annual Report 2023: LEO Pharma Delivers 10% Revenue Growth and Returns to Positive EBITDA
February 29, 2024
From LEO Pharma
Via Business Wire
From LEO Pharma
Via Business Wire
Temtokibart achieves First Subject First Treatment (FSFT) milestone in Phase 2b trial
October 11, 2023
From LEO Pharma
Via Business Wire
Globally Known Professor and Dermatologist Joins LEO Pharma
October 09, 2023
From LEO Pharma
Via Business Wire
LEO Pharma delivers solid first half-year results and strengthens its capital structure
September 12, 2023
From LEO Pharma
Via Business Wire
LEO Pharma announces changes to its Global Leadership Team
August 28, 2023
From LEO Pharma
Via Business Wire
LEO Pharma Signs Agreement to Acquire Timber Pharmaceuticals
August 21, 2023
From LEO Pharma
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.